S. Janes (London, United Kingdom), A. Rozman (Golnik, Slovenia)
Cytology sample from EBUS-TBNA for multi-gene analysis in non-small-cell lung cancer (NSCLC)
C. Centeno Clemente, J. Sanz-Santos, F. Andreo, E. Carcereny, T. Moran, E. Castellà, M. Llatjòs, A. M. Muñoz-Mármol, J. L. Ramírez, R. Rosell, J. Ruiz-Manzano (Badalona, Spain)
|   |
Role of the EBUS-EUS-FNA combined approach by using single ultrasound bronchoscope for tissue diagnosis in mediastinal lymphadenopathy
A. Strunina, R. Kuvaev, S. Kashin, A. Levina, V. Chernyeva (Yaroslavl, Russian Federation)
| |
Qualitative and quantitative EBUS-elastography - an early feasibility study
T. Schneider, G. Benz, F. Baty, M. Brutsche (St. Gallen, Switzerland)
| |
Methilation status in EBUS-NA samples of lung cancer
L. Millares, G. Bermudo, L. Setó, C. Grimau, N. Combalia, M. R. Escoda, E. Castellà, M. Llatjos, F. Andreo, J. Sanz, C. Monton, M. Gallego, E. Monsó (Sabadell, Bunyola, Badalona, Spain)
| |
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
S. Tan, K. Sharma, K. Y. Tham, S. Y. Ang, V. H. Nguyen, T. S. Lapperre, C. M. Loo, M. S. Koh (Singapore, Singapore)
| |
The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
T. Terashi, N. Tanaka, Y. Tone, S. Iimori, T. Osako, R. Miyahara (Kyoto-shi, Japan)
| |
Functional respiratory imaging to predict post-operative FEV1 after lobectomy/pneumonectomy
W. Vos, A. Janssens, C. Van Holsbeke, G. Leemans, J. De Backer, W. De Backer, P. Van Schil, J. van Meerbeeck (Kontich, Edegem, Belgium)
| |
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
M. Evison, P. Crosbie, J. Martin, P. Barber, R. Booton, K. Hilton (Manchester, United Kingdom)
| |
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
F. Yildirim, A. S. Yurdakul, M. Türk, U. O. Akdemir, C. Öztürk (Ankara, Turkey)
| |
The roles of Ki-67, p53, transforming growth factor- and lysyl oxidase in the metastasis of lung cancer
O. Araz, E. Demirci, E. Yilmazel Ucar, M. Calik, A. Karaman, I. Durur Subasi, E. Orsal, M. Subasi, F. Daloglu, M. Akgun (Erzurum, Turkey)
| |
Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
G. Edwards, A. Thahseen, I. Williamson, S. Williams, H. Howison, A. Ionescu (Newport, United Kingdom)
| |
Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
E. Kurtipek, M. çayci, N. Düzgün, H. Esme, S. Baktik, M. S. Aygün, Y. Ünlü, C. Burnik, T. T. Bekçi, Y. Terzi (Konya, Samsun, Turkey)
| |
Early diagnosis of lung cancer by the electronic nose: Preliminary results
G. Sedda, R. Gasparri, J. Guarize, D. Brambilla, A. Borri, M. Santonico, G. Pennazza, C. Di Natale, R. Paolesse, A. D'Amico, L. Spaggiari (Rome, Milan, Italy)
| |
Electronic nose as a screening tool for early stage lung cancer
A. Dent, R. Bowman, P. Zimmerman, I. Yang, K. Fong (Brisbane, Australia)
| |
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
S. Cameron, K. Lewis, M. Beckmann, G. Allison, R. Ghosal, P. Lewis, L. Mur (Aberystwyth, Llanelli, Swansea, United Kingdom)
| |
National lung cancer tissue diagnosis targets: Are they achievable?
A. MacKenzie, J. Martin, F. Wood (Larbert, United Kingdom)
| |
Improving NLST criteria for lung cancer screening
P. Sanchez, J. P. De-Torres, D. O. Wilson, J. Weissfeld, A. Campo, A. B. Alcaide, J. Zulueta (Pamplona, Spain; Pittsburgh, United States Of America)
| |
False alarms: Negative invasive procedures and negative additional imaging after the introduction of a CT-based follow-up program in lung cancer patients treated with curative intent
N. C. G. Hansen (Odense, Denmark)
| |